Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1233249.RAJOqdi-MAkk4sCKuwqIllz7ApCFUBwtF8i0Pq9mfakgc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1233249.RAJOqdi-MAkk4sCKuwqIllz7ApCFUBwtF8i0Pq9mfakgc130_assertion type Assertion NP1233249.RAJOqdi-MAkk4sCKuwqIllz7ApCFUBwtF8i0Pq9mfakgc130_head.
- NP1233249.RAJOqdi-MAkk4sCKuwqIllz7ApCFUBwtF8i0Pq9mfakgc130_assertion description "[The present results indicated that LY294002 inhibits the malignant phenotype of OS cells via modulation of the PI3K/Akt/FASN signaling pathway in vitro and may be a new therapeutic strategy for the management of OS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233249.RAJOqdi-MAkk4sCKuwqIllz7ApCFUBwtF8i0Pq9mfakgc130_provenance.
- NP1233249.RAJOqdi-MAkk4sCKuwqIllz7ApCFUBwtF8i0Pq9mfakgc130_assertion evidence source_evidence_literature NP1233249.RAJOqdi-MAkk4sCKuwqIllz7ApCFUBwtF8i0Pq9mfakgc130_provenance.
- NP1233249.RAJOqdi-MAkk4sCKuwqIllz7ApCFUBwtF8i0Pq9mfakgc130_assertion SIO_000772 25351625 NP1233249.RAJOqdi-MAkk4sCKuwqIllz7ApCFUBwtF8i0Pq9mfakgc130_provenance.
- NP1233249.RAJOqdi-MAkk4sCKuwqIllz7ApCFUBwtF8i0Pq9mfakgc130_assertion wasDerivedFrom befree-2016 NP1233249.RAJOqdi-MAkk4sCKuwqIllz7ApCFUBwtF8i0Pq9mfakgc130_provenance.
- NP1233249.RAJOqdi-MAkk4sCKuwqIllz7ApCFUBwtF8i0Pq9mfakgc130_assertion wasGeneratedBy ECO_0000203 NP1233249.RAJOqdi-MAkk4sCKuwqIllz7ApCFUBwtF8i0Pq9mfakgc130_provenance.